Internal Medicine · Deming, NM
NPI
1750495966
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
122 S Gold Ave, Suite 3
Deming, NM, 88030
Phone (505) 544-7280
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$1.8M
20,118 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Fernando J Pardo-Ruiz prescribed most often to Medicare patients was Atorvastatin Calcium, with 1,373 prescriptions and refills. In total Fernando J Pardo-Ruiz wrote 20,118 Medicare prescriptions that cost $1.8M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-09-26.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Atorvastatin Calcium Generic | 1,373 | 1,373 | 113 | $21K |
| Memantine Hcl Generic | 701 | 701 | 52 | $13K |
| Levothyroxine Sodium Generic | 680 | 680 | 49 | $11K |
| Gabapentin Generic | 662 | 662 | 56 | $10K |
| Furosemide Generic | 585 | 586 | 51 | $8,458 |
| Tamsulosin Hcl Generic | 559 | 561 | 51 | $9,860 |
| Sertraline Hcl Generic | 535 | 535 | 40 | $8,326 |
| Losartan Potassium Generic | 519 | 520 | 45 | $7,900 |
| Metoprolol Succinate Generic | 514 | 514 | 44 | $8,127 |
| Allopurinol Generic | 478 | 478 | 32 | $7,792 |
| Carvedilol Generic | 438 | 438 | 29 | $6,671 |
| Metformin Hcl Er Metformin Hcl | 423 | 423 | 38 | $6,734 |
| Ozempic Semaglutide | 375 | 387 | 38 | $359K |
| Lisinopril Generic | 316 | 320 | 33 | $4,576 |
| Amlodipine Besylate Generic | 311 | 311 | 31 | $4,411 |
Brand drugs: 2,682 claims; generic drugs: 17,321 claims; opioid claims: 128.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Fernando J Pardo-Ruiz were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.